Pharming, Laboratorios del Dr. Esteve S.A. deal

PHARM licensed its recombinant human C1 inhibitor ( rhC1INH) to Laboratorios del Dr. Esteve. The partners will develop, market and sell rhC1INH in Spain, Portugal and Greece to treat hereditary angioe...